High-intensity statin therapy for chronic coronary disease — ACC/AHA · 2023 recommendation
2023 AHA/ACC chronic coronary disease guideline
For chronic coronary disease, high-intensity statin therapy is recommended to reduce cardiovascular events; if it is not tolerated, use the maximally tolerated statin intensity.
Class of Recommendation
Class 1
Level of Evidence
Level A
Last source-check date
2026-08-23
Exact source location
Section 4.2.6, ‘Lipid Management’, recommendation table, p. e37
Prepared source-record governance
This record is prepared from a stored source. It is not labelled reviewer-verified because named reviewer provenance has not been documented.
- Clinical reviewer
- Not yet documented.
- Reviewer credentials
- Not yet documented.
- Last source-check date
- 2026-08-23
- Second-review status
- Not yet documented.
- Conflict-of-interest declaration
- Not yet documented.
- Source publication date
- Not yet documented.
- Source access date
- Not yet documented.
- Record version
- Not yet documented.
- Change history
- Not yet documented.
- Next review date
- Not yet documented.
Verification status & editorial record
Status: Prepared source record — reviewer provenance not documented.
Last source-check: 2026-08-23
No formally approved public metadata is currently available for a named reviewer, second-review status, conflict declaration, publication or access date, version history, or next review date for this record.
Verification boundary: This concise reference is limited to a prepared source recommendation. Verify the official document, local protocol, and patient context before application.